Transplant Surgery Practice Questions

Q: Solution currently used for liver preservation for transplantation is?

University of Wisconsin (UW) solution. ***University of Wisconsin (UW) solution*** - The **University of Wisconsin (UW) solution** is widely considered the gold standard for **organ preservation**, particularly for liver transplantation, due to its superior ability to extend cold ischemia time. - It contains a unique blend of components, including **lactobionate, raffinose, and hydroxyethyl starch**, which help to minimize cellular swelling, prevent free radical injury, and maintain cellular integrity during cold storage. *IGL-1 solution* - **IGL-1** is a more recent preservation solution designed to be used with **machine perfusion** systems. - While showing promise, it is **not yet as universally adopted** as UW solution for static cold storage of livers. *Ross Marshall Citrate solution* - The **Ross Marshall Citrate solution** was an older solution primarily used for **kidney preservation**. - It has been largely **superseded by newer solutions** with improved efficacy for liver and other organ preservation. *Kyoto ET solution* - **Kyoto ET solution** is another preservation solution primarily used in **Japan**, particularly for **kidney and pancreas preservation**. - While effective for those organs, it is **not the most commonly used** or preferred solution for liver preservation globally.

Q: Which solid organ is considered to have the lowest risk of rejection during transplantation?

Liver. ***Liver*** - The liver has a unique immunologic environment, often referred to as **immunologic privilege**, which contributes to its lower rates of rejection compared to other transplanted solid organs. - It produces various **immunosuppressive factors** and has a high capacity for regeneration and repair, adapting more readily to the recipient's immune system. - The liver's **dual blood supply** (hepatic artery and portal vein) and tolerogenic properties make it the most immunologically privileged solid organ. *Pancreas* - **Pancreas transplantation** carries a high risk of rejection, with rejection rates significantly higher than liver transplantation. - Pancreatic tissue is highly **immunogenic** due to its endocrine and exocrine functions, requiring aggressive immunosuppression. - Often transplanted with kidney in diabetic patients, and rejection episodes are common. *Kidney* - Kidney transplantation is common, but it carries a significant risk of both **acute and chronic rejection**, requiring lifelong immunosuppression. - The kidney expresses various **MHC antigens** that are readily recognized by the recipient's immune system, making it more immunogenic than the liver. *Heart* - **Heart transplantation** is associated with a high risk of rejection due to the rich vascularity and immunogenicity of cardiac tissue. - It often requires aggressive immunosuppressive regimens to prevent both **acute cellular rejection** and **antibody-mediated rejection**.

Q: Which of the following drugs is not part of the standard immunosuppressive therapy for post-renal transplant patients?

Rituximab. ***Rituximab*** - **Rituximab** is a monoclonal antibody targeting **CD20 on B-lymphocytes**, primarily used in lymphomas, leukemias, and some autoimmune diseases. - While it can be used in highly selected cases for antibody-mediated rejection, it is **not considered standard immunosuppressive therapy** for maintenance of post-renal transplant patients. *Cyclosporine* - **Cyclosporine** is a **calcineurin inhibitor** that plays a central role in most maintenance immunosuppression regimens after renal transplant. - It works by inhibiting the activation of T-lymphocytes, thereby **preventing organ rejection**. *Azathioprine* - **Azathioprine** is an **antimetabolite** that inhibits lymphocyte proliferation and is a common component of standard immunosuppressive regimens. - It works by interfering with purine synthesis, thus **suppressing the immune response**. *Prednisolone* - **Prednisolone** (a corticosteroid) is a fundamental component of most immunosuppressive protocols for **renal transplant recipients**. - It provides broad-spectrum immunosuppression by reducing inflammation and suppressing various immune cells.

Q: Which of the following is an indication for lung transplantation?

All of the options. ***All of the options*** - **COPD**, **Alpha-1 antitrypsin deficiency**, and **Cystic fibrosis** with **bronchiectasis** are all common indications for lung transplantation when medical management fails and the patient meets other criteria. - Lung transplantation is considered for patients with **end-stage lung disease** who have a high risk of death within 1-2 years without transplantation, and who have no significant comorbidities. *COPD* - While many patients with **COPD** manage with medical therapy, those with severe disease, frequent exacerbations, and **declining lung function** despite maximal treatment can be candidates for lung transplantation. - **End-stage COPD** is a significant cause of morbidity and mortality, making transplantation a viable option for selected patients. *Alpha-1 antitrypsin deficiency* - This genetic disorder primarily affects the lungs, leading to **early-onset emphysema** and **bronchiectasis**, particularly in non-smokers. - When the lung damage progresses to a severe and life-threatening stage, **lung transplantation** becomes a treatment option. *Cystic fibrosis and bronchiectasis* - **Cystic fibrosis** often leads to severe, progressive **bronchiectasis** and chronic lung infections, resulting in **end-stage lung disease**. - For these patients, especially those with intractable daily symptoms and **declining respiratory function**, lung transplantation can significantly improve quality of life and survival.

Q: What is the term used for transplantation of tissue from one part of a patient's body to another part of the same patient's body?

Autograft. ***Autograft*** - An **autograft** refers to the transplantation of tissue from one part of an individual's body to another part of the **same individual's body**. - This type of transplant has the lowest risk of **immune rejection** as the tissue is genetically identical to the recipient's body. *Allograft* - An **allograft** involves the transplantation of tissue between two genetically distinct individuals of the **same species**. - While often successful, allografts carry a significant risk of **immune rejection**, necessitating immunosuppressive therapy. *Isograft* - An **isograft** is a transplant between genetically identical individuals, such as **monozygotic (identical) twins**. - Like autografts, isografts have a minimal risk of immune rejection due to their shared genetic makeup. *Xenograft* - A **xenograft** involves the transplantation of tissue between individuals of **different species**. - This type of transplant carries the highest risk of **immune rejection** and often requires extensive genetic modification of the donor tissue or aggressive immunosuppression.

Q: Which of the following is category 3 in the Maastricht classification of donation after cardiac death?

Awaiting cardiac arrest. ***Awaiting cardiac arrest*** - This category denotes patients who are anticipated to have a **cardiac arrest** and are considered for organ donation after the cessation of circulatory function. - These individuals are typically in an **intensive care setting**, where withdrawal of life support is planned, leading to eventual cardiac death. *Patient found deceased upon arrival* - This describes individuals who have suffered **unwitnessed cardiac arrest** and are pronounced dead upon the arrival of medical personnel. - Organ viability for donation is often compromised due to the **unknown downtime** and lack of controlled conditions. *Attempts at resuscitation after cardiac arrest* - This category includes patients for whom **resuscitation efforts** were initiated following cardiac arrest but were ultimately unsuccessful. - Organ donation in this context requires assessment of the impact of resuscitation on **organ perfusion** and viability. *Cardiac arrest following brain death declaration* - This scenario describes donation after **neurological determination of death** (brain death), not cardiac death. - In brain death, the heart may still be beating with full circulatory support, and organ procurement occurs while **circulation is maintained**.

Q: What is the method of delivery for islet cell transplantation in diabetes mellitus?

Infused into the portal vein. ***Infused into the portal vein*** - Islet cells are infused into the **portal vein**, which carries them to the liver, where they engraft and begin producing insulin. - The **liver** provides a rich blood supply and an immunosuppressive environment favorable for islet survival and function. *Pelvis* - While other cell therapies might be delivered to the pelvis, it is not the standard site for **islet cell transplantation**. - The pelvis lacks the specific microenvironment and blood flow dynamics optimal for islet engraftment and function. *Thigh* - The thigh is not a typical site for **islet cell transplantation** due to its less favorable vascularization and tissue environment compared to the liver. - Delivering islets to the thigh would likely result in poorer survival and integration of the transplanted cells. *Forearm muscles* - **Forearm muscles** are not the preferred location for islet cell transplantation due to inadequate blood supply and an unsuitable immunological environment. - This site would not optimize cell survival or insulin secretion.

Q: All of the following are indications for liver transplantation, except for which of the following?

Alcoholic Hepatitis. ***Alcoholic Hepatitis*** - Traditionally, **active alcoholic hepatitis with ongoing alcohol use** is a contraindication to liver transplantation. - Patients must demonstrate a sustained period of **abstinence** (typically 6 months minimum) and commitment to sobriety before being considered for transplant. - **Active alcohol use** poses risks of recidivism, non-compliance, and disease recurrence post-transplant. - Note: Some specialized centers now consider early transplant for severe alcoholic hepatitis in highly selected cases, but this remains controversial and not standard practice. *Hepatocellular Carcinoma* - **Hepatocellular carcinoma (HCC)** meeting specific criteria (e.g., **Milan criteria**: single lesion ≤5 cm or up to 3 lesions each ≤3 cm, no vascular invasion) is a well-established indication for liver transplantation. - Transplantation offers the best chance for cure by removing both the tumor and the underlying cirrhotic liver. *Cirrhosis* - **Decompensated cirrhosis** is the most common indication for liver transplantation, regardless of etiology (viral, autoimmune, metabolic, alcoholic after abstinence). - Complications like refractory ascites, hepatic encephalopathy, variceal bleeding, and hepatorenal syndrome indicate need for transplant evaluation. *Biliary Atresia* - **Biliary atresia** is the most common indication for pediatric liver transplantation. - This congenital condition involves obstruction or absence of extrahepatic bile ducts, leading to progressive cholestasis, cirrhosis, and liver failure if untreated.

Q: According to the Maastricht classification, Category 3 is?

awaiting cardiac arrest after withdrawal of support. ***awaiting cardiac arrest after withdrawal of support*** - Under the **Maastricht classification**, Category 3 describes patients who are **expected to die** following the planned withdrawal of life-sustaining treatment. These patients are potential donors after circulatory death (DCD). [1], [2] *dead on arrival to hospital* - This scenario aligns with **Maastricht Category 1** (Uncontrolled DCD), where death occurs outside the hospital setting without prior intervention. - Patients in this category often have unpredictable warm ischemia times, making organ procurement challenging for some organs. *resuscitation attempted without success* - This situation aligns with **Maastricht Category 2** (Uncontrolled DCD), referring to patients declared dead after unsuccessful resuscitation efforts in the emergency department or hospital. - The period of observed death following resuscitation attempts is crucial for determining organ viability. *cardiac arrest while brain dead* - This describes a patient who is **brain dead** but still has some circulatory function, which eventually ceases. This is typically associated with organ donation after brain death (DBD), not the DCD categories defined by Maastricht. [1], [3] - In brain death, the **neurological criteria for death** are met, regardless of circulatory status at the time of diagnosis. [2], [4]

Q: Liver transplant for which of the following conditions will require a duct-to-jejunal anastomosis rather than a duct-to-duct anastomosis?

Primary sclerosing cholangitis. ***Primary sclerosing cholangitis*** - **Primary sclerosing cholangitis (PSC)** is characterized by **inflammation and scarring of the bile ducts**, leading to strictures and impaired bile flow. - Due to the widespread nature of the disease and the potential for residual diseased ducts in the recipient, a **duct-to-jejunal anastomosis (Roux-en-Y hepaticojejunostomy)** is preferred to ensure optimal drainage and avoid complications like cholangitis and anastomotic strictures at the native duct. *Alagille syndrome* - **Alagille syndrome** is a genetic disorder causing **bile duct paucity and cholestasis**. - While it affects the bile ducts, the native large bile duct in the recipient is often suitable for a **duct-to-duct anastomosis** without significant risk of recurrent disease-related strictures. *Liver cirrhosis* - **Cirrhosis** from most causes (e.g., viral hepatitis, alcohol) primarily affects the **liver parenchyma**, not the bile ducts directly. - In such cases, the native bile duct is usually healthy, allowing for a straightforward **duct-to-duct anastomosis**. *Primary biliary cholangitis* - **Primary biliary cholangitis (PBC)** is an autoimmune disease primarily affecting the **small intrahepatic bile ducts**. - The larger extrahepatic bile ducts are typically spared and healthy, making a **duct-to-duct anastomosis** the standard and preferred method for bile drainage after transplant.

Question 1

Solution currently used for liver preservation for transplantation is?

Accepted Answer

University of Wisconsin (UW) solution

Answer

IGL-1 solution

Answer

Ross Marshall Citrate solution

Answer

Kyoto ET solution

Question 2

Which solid organ is considered to have the lowest risk of rejection during transplantation?

Accepted Answer

Liver

Answer

Pancreas

Answer

Kidney

Answer

Heart

Question 3

Which of the following drugs is not part of the standard immunosuppressive therapy for post-renal transplant patients?

Accepted Answer

Rituximab

Answer

Cyclosporine

Answer

Azathioprine

Answer

Prednisolone

Question 4

Which of the following is an indication for lung transplantation?

Accepted Answer

All of the options

Answer

COPD

Answer

Alpha-1 antitrypsin deficiency

Answer

Cystic fibrosis and bronchiectasis

Question 5

What is the term used for transplantation of tissue from one part of a patient's body to another part of the same patient's body?

Accepted Answer

Autograft

Answer

Allograft

Answer

Isograft

Answer

Xenograft

Question 6

Which of the following is category 3 in the Maastricht classification of donation after cardiac death?

Accepted Answer

Awaiting cardiac arrest

Answer

Patient found deceased upon arrival

Answer

Attempts at resuscitation after cardiac arrest

Answer

Cardiac arrest following brain death declaration

Question 7

What is the method of delivery for islet cell transplantation in diabetes mellitus?

Accepted Answer

Infused into the portal vein

Answer

Thigh

Answer

Pelvis

Answer

Forearm muscles

Question 8

All of the following are indications for liver transplantation, except for which of the following?

Accepted Answer

Alcoholic Hepatitis

Answer

Hepatocellular Carcinoma

Answer

Biliary atresia

Answer

Cirrhosis

Question 9

According to the Maastricht classification, Category 3 is?

Accepted Answer

awaiting cardiac arrest after withdrawal of support

Answer

dead on arrival to hospital

Answer

resuscitation attempted without success

Answer

cardiac arrest while brain dead

Question 10

Liver transplant for which of the following conditions will require a duct-to-jejunal anastomosis rather than a duct-to-duct anastomosis?

Accepted Answer

Primary sclerosing cholangitis

Answer

Alagille syndrome

Answer

Liver cirrhosis

Answer

Primary biliary cholangitis

Transplant Surgery — MCQs

Transplant Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?